Antineutrophil cytoplasmic antibodies: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett (New page: {{subpages}} In medicine and rheumatology, '''antineutrophil cytoplasmic antibodies''' ('''ANCA''') are "Autoantibodies directed against cytoplasmic constituents o...) |
(No difference)
|
Revision as of 11:29, 3 October 2008
In medicine and rheumatology, antineutrophil cytoplasmic antibodies (ANCA) are "Autoantibodies directed against cytoplasmic constituents of polymorphonuclear leukocytes and/or monocytes. They are used as specific markers for Wegener Granulomatosis and other diseases, though their pathophysiological role is not clear. ANCA are routinely detected by indirect immunofluorescence with three different patterns: c-ANCA (cytoplasmic), p-ANCA (perinuclear), and atypical ANCA."[1]
References
- ↑ Anonymous (2024), Antineutrophil cytoplasmic antibodies (English). Medical Subject Headings. U.S. National Library of Medicine.